Skip to main content
Neurology® Neuroimmunology & Neuroinflammation logoLink to Neurology® Neuroimmunology & Neuroinflammation
. 2020 Jul 8;7(5):e850. doi: 10.1212/NXI.0000000000000850

Guillain-Barré syndrome related to SARS-CoV-2 infection

PMCID: PMC7422708  PMID: 32646886

In the Article “Guillain-Barré syndrome related to SARS-CoV-2 infection” by K. Bigaut et al.,1 there are several errors in table 1. The age noted for the patient described in the first case should be 43; additionally, the protein level in CSF should be listed as 0.94 g/L for this patient. Lastly, for the patient described in the second case, the protein level in CSF should be listed as 1.06 g/L. The authors regret the errors.

Reference


Articles from Neurology® Neuroimmunology & Neuroinflammation are provided here courtesy of American Academy of Neurology

RESOURCES